A potent and selective catalytic inhibitor of p300/CBP histone acetyltransferases suppresses tumour proliferation across multiple cell lineages, illustrating the therapeutic potential of drug-like small molecules that target histone acetyltransferases.
- Loren M. Lasko
- Clarissa G. Jakob
- Kenneth D. Bromberg